Years of experience as a global leader in eye care have resulted in the rapid growth of Allergan's ophthalmic pharmaceuticals business.  With an expertise in discovering and developing new therapeutic agents for conditions and diseases of the eye, Allergan is positioning itself to take over the No. 1 position in the global ophthalmic market by establishing the largest ophthalmic sales force in the world and by making significant investments in eye care research and development projects.  

Allergan’s eye care products are focused around treatments for glaucoma, ocular allergy and infections, retinal disease and dry eyes.